Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors

Cancer Letters

Volumn 199, Issue 1, 2003, Pages 69-73

  Takano, Toru ^a   Miyauchi, Akira ^b   Matsuzuka, Fumio ^b   Yoshida, Hiroshi ^b   Kuma, Kanji ^b   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

Aspiration biopsy RNA diagnosis; Galectin 3; mRNA; Thyroid carcinoma

Indexed keywords

BETA ACTIN; GALECTIN 3; MESSENGER RNA;

ADENOMA; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CONTROLLED STUDY; DISEASE SEVERITY; FIBROBLAST; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; THYROID CANCER; TISSUE DISTRIBUTION;

EID: 0042881126     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00343-4     Document Type: Article

References (18)

1. Hamburger J.I. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J. Clin. Endocrinol. Metab. 79:1994;335-339.
2. Yokozawa T., Miyauchi A., Kuma K., Sugawara M. Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid. 5:1995;141-145.
3. Cooper D.S., Schneyer C.R. Follicular and Hurthle cell carcinoma of the thyroid. Endocrinol. Metab. Clin. North Am. 19:1990;577-591.
4. Takano T., Amino N. Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis. Endocr. J. 49:2002;97-107.
5. Takano T., Miyauchi A., Yokozawa T., Matsuzuka F., Liu G., Higashiyama T., Morita S., Kuma K., Amino N. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res. 58:1998;4913-4917.
6. Takano T., Miyauchi A., Matsuzuka F., Liu G., Higashiyama T., Yokozawa T., Kuma K., Amino N. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J. Clin. Endocrinol. Metab. 84:1999;951-955.
7. Takano T., Shiba E., Tada H., Yoshimura H., Yoshida K., Doi R., Amino N. Preoperative diagnosis of thyroid carcinomas by aspiration biopsy-reverse transcription-polymerase chain reaction (ABRP): a report of two cases. Endocr. J. 47:2000;271-275.
8. Bartolazzi A., Gasbarri A., Papotti M., Bussolati G., Lucante T., Khan A., Inohara H., Marandino F., Orlandi F., Nardi F., Vecchione A., Tecce R., Larsson O. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 357:2001;1644-1650.
9. Bernet V.J., Anderson J., Vaishnav Y., Solomon B., Adair C.F., Saji M., Burman K.D., Burch H.B., Ringel M.D. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J. Clin. Endocrinol. Metab. 87:2002;4792-4796.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Takano T., Miyauchi A., Matsuzuka F., Kuma K., Amino N. Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: a possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas. J. Clin. Endocrinol. Metab. 85:2000;765-768.
12. Takano T., Miyauchi A., Yokozawa T., Matsuzuka F., Maeda I., Kuma K., Amino N. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res. 59:1999;4542-4545.
13. Xu X.C., el-Naggar A.K., Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am. J. Pathol. 147:1995;815-822.
14. Orlandi F., Saggiorato E., Pivano G., Puligheddu B., Termine A., Cappia S., De Giuli P., Angeli A. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res. 58:1998;3015-3020.
15. Martins L., Matsuo S.E., Ebina K.N., Kulcsar M.A., Friguglietti C.U., Kimura E.T. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J. Clin. Endocrinol. Metab. 87:2002;4806-4810.
16. Takano T., Matsuzuka F., Sumizaki H., Kuma K., Amino N. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. Cancer Res. 57:1997;3792-3797.
17. Huang Y., Prasad M., Lemon W.J., Hampel H., Wright F.A., Kornacker K., LiVolsi V., Frankel W., Kloos R.T., Eng C., Pellegata N.S., de la Chapelle A. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc. Natl Acad. Sci. USA. 98:2001;15044-15049.
18. Bartolazzi A., Papotti M., Orlandi F. Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules. J. Clin. Endocrinol. Metab. 88:2003;950.